Medicus Pharma: Targeting Urinary Retention with a Novel Non-Invasive Therapy
Medicus Pharma is introducing a groundbreaking therapy to prevent relapse in men suffering from acute urinary retention due to enlarged prostate.
Advancing prostate health with innovation backed by proven biotech pioneers
Every year, nearly 1 million men in the U.S. face the sudden and painful onset of acute urinary retention (AUR)—a medical emergency that often leads to repeat ER visits. Medicus Pharma, known for developing the revolutionary skin cancer patch, is now addressing this urgent need with a non-invasive therapy designed to prevent relapse.
Targeting a $2 billion market, Medicus Pharma’s solution could change how prostate-related emergencies are managed, offering relief and reducing the likelihood of recurrence. With a legacy of biotech innovation and a clear clinical focus, Medicus is advancing a therapy that meets an immediate and recurring need for millions.
To learn more about Medicus Pharma (NASDAQ: MDCX), watch their video HERE
Published by BTV - The Agency
Discover Investment Opportunities with BTV. Delivering engaging content to Investors for 25+ years.
You might also like
CEO Clip - Southern Silver: Can a Growing Silver Resource Support a Major Underground Mine in Mexico?
Southern Silver is advancing the Cerro Las Minitas silver-lead-zinc project in Durango, Mexico, where additional drilling is being incorporated into an updated mineral resource estimate and Preliminary Economic Assessment.
Southern Silver: Is Cerro Las Minitas Emerging as a Major Silver Project?
Southern Silver is advancing its flagship Cerro Las Minitas silver-lead-zinc project in Mexico, which management describes as one of the larger, higher-grade silver-based projects globally.
ASTER BRINGS VERTICAL INTEGRATION TO CLINCH RESOURCES
For the next generation of mining companies, success may depend on more than what comes out of the ground. It may also depend on how much of the value chain a company can control. That’s the thinking behind high-quality metallurgical and specialty coal producer Clinch Resources’ (TSX: CLCH) vertically integrated approach, which brings specialized capabilities like those of its subsidiary Aster Resources — Clinch’s mine-to-market platform — under the same corporate umbrella. By combining mining expertise with the infrastructure, logistics and commercial capabilities needed to move its product to market, Clinch is building a more connected business designed to capture greater value at every stage.